Clinical trials: PFO

Migraine, Patent Foramen Ovale

GORE® CARDIOFORM Septal Occluder Migraine Clinical Study

• Terminated
• Age: 18 to 55 years
• Medical device
• Results posted

Multi-center, prospective, randomized, placebo- and sham-controlled study to evaluate the GORE® CARDIOFORM Septal Occluder for migraine headache relief

Conditions

Migraine, Patent Foramen Ovale, PFO - Patent Foramen Ovale

Trial name

RELIEF (NCT04100135)

Testing

Actual device PFO closure, Thienopyridine (clopidogrel or prasugrel)

Where

15 sites in United States

Volunteers

7 people, healthy volunteers welcome

Sponsor

W.L.Gore & Associates